JPMorgan raised the firm’s price target on Procter & Gamble to $165 from $163 and keeps a Neutral rating on the shares. The firm updated the company’s model post the fiscal Q1 report. It views Procter’s guidance as conservative.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target lowered to $175 from $180 at Morgan Stanley
- Procter & Gamble: Strong Performance and Future Potential Justify Buy Rating
- Procter & Gamble: Buy Rating Affirmed Amidst Growth Potential and Strategic Reinvestment
- Procter & Gamble’s Leadership Cautious: No Trading Arrangements in Q3 2025 Raises Investor Concerns
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!